Table 3 PDX biobanks
From: Patient-derived xenograft models in cancer therapy: technologies and applications
Affiliation | Reference/website | Number of PDX cases | Cancer type |
|---|---|---|---|
NCI Patient-Derived Models Repository | Over 1000 | Pan-cancer | |
Princess Marget Living Biobank | Over 850 | Pan-cancer | |
The Center for Patient Derived Models at Dana Farber Cancer Institute | Center for Patient Derived Models (CPDM) - Dana-Farber Cancer Institute | Boston, MA | Over 700 | Pan-cancer |
Candiolo Cancer Institute | Over 700 | Gastric cancer and colorectal cancer | |
Charles River Laboratories | Patient-Derived Xenograft: PDX Models | Charles River (criver.com) | Over 450 | Pan-cancer |
Washington University in St. Louis | PDXdb: Washington University PDX Development and Trial Center | PDXdb (wustl.edu) | Over 300 | Pan-cancer |
Pediatric Preclinical In Vivo Testing Consortium | Over 250 | Pediatric tumors | |
St. Jude Children’s Research Hospital | Home | Childhood Solid Tumor Network (CSTN) Data Portal | St. Jude Cloud (stjude.cloud) | Over 150 | Pediatric solid tumors |
Vall d’Hebron Institute of Oncology | Over 70 | Breast carcinoma, pancreas cancer, colorectal cancer | |
Luxembourg Institute of Health | Over 40 | Glioma | |
J-PDX | Over 290 | Pan-cancer |
